Silverfleet expands London team

Silverfleet Capital has appointed Jack Priestman as an analyst, based in its London office. Priestman was formerly at Perella Weinberg Partners in London as an Analyst in the generalist M&A advisory team.

Silverfleet-backed Aesica expands

UK-based pharmaceutical manufacturer Aesica has announced the creation of a new high capacity manufacturing facility following an investment at its Queenborough, Kent site. The company is backed by Silverfleet Capital.

Silverfleet Capital to Buy Ipes

European private equity firm Silverfleet Capital is to buy Ipes, a provider of fund administration and outsourcing services to the private equity industry, from RJD Partners. The deal is valued at 50 million pounds ($76.5 million).

Silverfleet Capital Promotes Three

European private equity firm Silverfleet Capital has promoted three of its investment team. Mark Piasecki, who is based in London, has been promoted to principal. Robert Knight, also based in London, and Cyril Bourdarot who is based in Paris, have become investment executives.

Silverfleet’s Aesica Pharmaceuticals Appoints Non-Exec Chairman

Aesica Pharmaceuticals, a pharmaceutical contract manufacturer backed by European private equity firm Silverfleet Capital has appointed David Greensmith as non-executive chairman. Greensmith’s previous executive roles include managing director of Fujifilm Imaging Colorants and COO of Avecia Group. PRESS RELEASE One of the fastest growing businesses in the UK, Aesica Pharmaceuticals, the pharmaceutical contract manufacturer backed […]

Silverfleet’s OFFICE Appoints to Board

London-based Footwear retailer OFFICE, backed by European private equity firm Silverfleet Capital has appointed Allan Leighton as non-executive chairman. This is the second senior appointment to the board after Ian Findlay joined as finance director in September. PRESS RELEASE Young fashion footwear retailer OFFICE, backed by Silverfleet Capital the European private equity firm, today reported […]

Silverfleet Takes on LDC Investment

London-based private equity firm Silverfleet Capital has agreed a majority investment with Aesica Pharmaceuticals replacing that of LDC. Members of Aesica’s executive team will reinvest a significant amount of money for a large minority stake. Debt is being provided by Lloyds, HSBC and Yorkshire Bank.Headquartered near Newcastle, UK, Aesica has the expertise to both develop and manufacture primary (API) and secondary stage (finished product dosage forms) pharmaceuticals.

GTCR Completes Sterigenics Buy

Buyout shop GTCR has completed its acquisition of Sterigenics International Inc., a provider of contract sterilization and ionization services for medical devices, food products and other applications. The firm bought Oak Brook, Illinois-based Sterigenics from Silverfleet Capital and PPM America Capital Partners. Terms were not released. Jefferies & Company, Bank of America Merrill Lynch and UBS advised GTCR on the transaction.

Silverfleet Plans To Sell Sterigenics

(Reuters) – Private equity firm Silverfleet Capital is seeking to sell Sterigenics, the Chicago-based firm whose gamma-ray sterilisation technology is used by medical device makers, sources familiar with the situation said on Thursday.

Silverfleet is hoping the business, which it bought in 2004, will fetch about $800 million and expects it will attract interest from private equity firms and trade bidders, the sources said.

Silverfleet declined comment. Sterigenics’s listed competitors include Steris Corp (STE.N) and Canada’s MDS Nordion (MDS.TO).

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget